(Q36983861)

17 August 2017

1 reference

title

Beneficial drugs for liver diseases (English)

1 reference

17 August 2017

Pablo Muriel

1

1 reference

17 August 2017

Yadira Rivera-Espinoza

series ordinal

2

1 reference

17 August 2017

language of work or name

English

0 references

publication date

1 March 2008

1 reference

Journal of Applied Toxicology

17 August 2017

published in

1 reference

17 August 2017

volume

28

1 reference

17 August 2017

issue

2

1 reference

17 August 2017

page(s)

93-103

1 reference

Molecular mechanism of the chemopreventive effect of resveratrol

17 August 2017

cites work

1 reference

Interferon alfa down-regulates collagen gene transcription and suppresses experimental hepatic fibrosis in mice

21 January 2018

1 reference

Protective effect of resveratrol on ethanol-induced lipid peroxidation in rats

21 January 2018

1 reference

Inhibitory effects of curcumin and tetrahydrocurcuminoids on the tumor promoter-induced reactive oxygen species generation in leukocytes in vitro and in vivo.

21 January 2018

1 reference

Resveratrol, a polyphenolic compound found in wine, inhibits tissue factor expression in vascular cells : A possible mechanism for the cardiovascular benefits associated with moderate consumption of wine

21 January 2018

1 reference

Thalidomide prevents bleomycin-induced pulmonary fibrosis in mice

21 January 2018

1 reference

Pegylated interferon-alpha plus taurine in treatment of rat liver fibrosis

21 January 2018

1 reference

Interferon augments the anti-fibrotic activity of an angiotensin-converting enzyme inhibitor in patients with refractory chronic hepatitis C.

21 January 2018

1 reference

S-adenosyl-L-methionine for alcoholic liver diseases.

21 January 2018

1 reference

12 January 2024

https://opencitations.net/index/api/v1/citations/10.1002/14651858.CD002235

Identifiers

DOI

10.1002/JAT.1310

1 reference

17 August 2017

1 reference